MIGA2
Mitoguardin 2
Also known as: C9orf54, FAM73B, FLJ00199, FLJ14596, MIGA2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7L4E1
- Gene
- MIGA2
- Ensembl
- ENSG00000148343
- Chromosome
- 9
- Canonical length
- 593 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Cell Junctions,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein heterodimerization activity and protein homodimerization activity. Involved in mitochondrial fusion. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
593 residues, UniProt reviewed canonical sequence.
>Q7L4E1|MIGA2
1 MAFRRAEGTS MIQALAMTVA EIPVFLYTTF GQSAFSQLRL TPGLRKVLFA TALGTVALAL
61 AAHQLKRRRR RKKQVGPEMG GEQLGTVPLP ILLARKVPSV KKGYSSRRVQ SPSSKSNDTL
121 SGISSIEPSK HSGSSHSVAS MMAVNSSSPT AACSGLWDAR GMEESLTTSD GNAESLYMQG
181 MELFEEALQK WEQALSVGQR GDSGSTPMPR DGLRNPETAS EPLSEPESQR KEFAEKLESL
241 LHRAYHLQEE FGSTFPADSM LLDLERTLML PLTEGSLRLR ADDEDSLTSE DSFFSATELF
301 ESLQTGDYPI PLSRPAAAYE EALQLVKEGR VPCRTLRTEL LGCYSDQDFL AKLHCVRQAF
361 EGLLEDKSNQ LFFGKVGRQM VTGLMTKAEK SPKGFLESYE EMLSYALRPE TWATTRLELE
421 GRGVVCMSFF DIVLDFILMD AFEDLENPPA SVLAVLRNRW LSDSFKETAL ATACWSVLKA
481 KRRLLMVPDG FISHFYSVSE HVSPVLAFGF LGPKPQLAEV CAFFKHQIVQ YLRDMFDLDN
541 VRYTSLPALA DDILQLSRRR SEILLGYLGV PAASSAGVNG ALPRENGPLG ELQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MIGA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 17 nTPM
- heart muscle: 16 nTPM
- small intestine: 15 nTPM
- bone marrow: 14 nTPM
- skeletal muscle: 9.6 nTPM
- tongue: 7.9 nTPM
Single-cell type
- platelets: 125 nCPM
- esophageal apical cells: 48 nCPM
- enterocytes: 46 nCPM
- erythrocyte progenitors: 41 nCPM
- colonocytes: 36 nCPM
- foveolar cells: 33 nCPM
Immune cell
- basophil: 7.7 nTPM
- MAIT T-cell: 3.6 nTPM
- neutrophil: 2.7 nTPM
- plasmacytoid DC: 2.3 nTPM
- memory CD8 T-cell: 2.2 nTPM
- intermediate monocyte: 1.9 nTPM
Brain region
- medulla oblongata: 23 nTPM
- thalamus: 20 nTPM
- pons: 20 nTPM
- cerebellum: 19 nTPM
- hypothalamus: 19 nTPM
- midbrain: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MIGA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MIGA2 as an antibody target. Whether an autoantibody or antibody against MIGA2 could matter depends on whether native MIGA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MIGA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MIGA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...